Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Endpoint:
acute toxicity: dermal
Type of information:
experimental study
Adequacy of study:
key study
Study period:
1966
Reliability:
2 (reliable with restrictions)
Rationale for reliability incl. deficiencies:
study well documented, meets generally accepted scientific principles, acceptable for assessment
Cross-reference
Reason / purpose for cross-reference:
reference to same study

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
1966
Report date:
1966

Materials and methods

Test guideline
Qualifier:
no guideline followed
Principles of method if other than guideline:
Clipped dorsal rabbit skin was wrapped with impervious film (secured by tape). Test substance was introduced through an opening (which was then sealed). Animals immobilized in FDA-type wooden stocks for up to 60 min. or 6 hours, then fitted with collars for 24 hrs to prevent oral uptake. 14-day observation and necropsy.
GLP compliance:
no
Test type:
other: Observation of systemic effects and mortality in skin irritation study
Limit test:
no

Test material

Constituent 1
Chemical structure
Reference substance name:
Trimethyl orthoformate
EC Number:
205-745-7
EC Name:
Trimethyl orthoformate
Cas Number:
149-73-5
Molecular formula:
C4H10O3
IUPAC Name:
trimethoxymethane
Details on test material:
- Name of test material (as cited in study report): Trimetyl orthoformate TMOF
- Substance type: pure active substance
- Physical state: liquid
- Analytical purity: 98%
- Impurities (identity and concentrations): no data
- Used as received

Test animals

Species:
rabbit
Strain:
other: Albino, not otherwise specified
Sex:
not specified

Administration / exposure

Type of coverage:
occlusive
Vehicle:
unchanged (no vehicle)
Details on dermal exposure:
TEST SITE
- Area of exposure: no data
- Type of wrap if used: impervious film, secured at each end with Elastoplast. Opening in the center back to introduce test substance, then closed with strip of adhesive
- 2-inch polyethylene collars to prevent oral uptake during first 24 hours (before washing)
- One experiment with 2250 mg/kg bw performed without occlusive wrap, loosely covered


REMOVAL OF TEST SUBSTANCE
- Washing (if done): with water, then dried
- Time after start of exposure: 24 hours

TEST MATERIAL
- Amount(s) applied (volume or weight with unit):
1) 2250 mg/kg bw (4.6 ml per animal, application site loosely covered)
2) 2250 mg/kg bw (5.9 ml per animal, application site wrapped with occlusive patch)
3) 3400 mg/kg bw (11.2 ml per animal, application site wrapped with occlusive patch)
- Concentration (if solution): 100% undiluted
- Constant concentration used: yes

VEHICLE
- none
Duration of exposure:
1) 55 minutes: 2250 mg/kg bw (application site loosely covered)
2) 1 hour: 2250 mg/kg bw (application site wrapped with occlusive patch)
3) 6 hours: 3400 mg/kg bw (application site wrapped with occlusive patch)
Doses:
2250 mg/kg bw (application site loosely covered, 55 min exposure)
2250 mg/kg bw (application site wrapped with occlusive patch, 1 hour exposure)
3400 mg/kg bw (application site wrapped with occlusive patch, 6 hours exposure)
No. of animals per sex per dose:
1 (sex not stated)
Control animals:
no
Details on study design:
- Duration of observation period following administration: 14 days
- Frequency of observations and weighing: no data
- Necropsy of survivors performed: yes
- Other examinations performed: clinical signs
Statistics:
None applied (1 animal per dose)

Results and discussion

Effect levels
Sex:
not specified
Dose descriptor:
LD0
Effect level:
>= 3 400 mg/kg bw
Based on:
test mat.
Remarks on result:
other: 6 hours exposure
Mortality:
None observed
Clinical signs:
other: None at 2250 mg/kg bw (1 hour exposure) Mild-moderate erythema on day one at 3400 mg/kg bw (6 hours exposure, occlusive); diminishing though 5 days No signs of systemic toxicity at any dose
Gross pathology:
No findings

Applicant's summary and conclusion

Interpretation of results:
GHS criteria not met
Conclusions:
The substance does not meet GHS classification criteria for acute dermal toxicity.